Log in to save to my catalogue

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary c...

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bce60bfbcb054c52a155d24cd58110aa

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series

About this item

Full title

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2020-07, Vol.24 (1), p.444-3, Article 444

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In a minority of patients, the disease may cause frequently lethal complications from acute respiratory distress syndrome to multisystem organ failure presumably driven by a cytokine storm [1]. [...]anti-cytokine therapies may be helpful to prevent tissue injury. Specifically, TNF may aggravate lymphopenia through direct killing via TNF/TNFR1 signa...

Alternative Titles

Full title

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bce60bfbcb054c52a155d24cd58110aa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bce60bfbcb054c52a155d24cd58110aa

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1466-609X,1366-609X

DOI

10.1186/s13054-020-03158-0

How to access this item